-+ 0.00%
-+ 0.00%
-+ 0.00%

DYNE THERAPEUTICS, - TO CONDUCT PHASE 1 PLACEBO-CONTROLLED TRIAL FOR DYNE-302 IN FSHD

路透·07/28/2026 11:30:00

登錄查看新聞詳情